A New Generation of IMiDs as Treatments for Neuroinflammatory and Neurodegenerative Disorders
| dc.contributor.author | Kopp, Katherine O. | |
| dc.contributor.author | Greer, Margaret E. | |
| dc.contributor.author | Glotfelty, Elliot J. | |
| dc.contributor.author | Hsueh, Shih-Chang | |
| dc.contributor.author | Tweedie, David | |
| dc.contributor.author | Kim, Dong Seok | |
| dc.contributor.author | Reale, Marcella | |
| dc.contributor.author | Vargesson, Neil | |
| dc.contributor.author | Greig, Nigel H | |
| dc.contributor.institution | University of Aberdeen.Medical Sciences | en |
| dc.contributor.institution | University of Aberdeen.Aberdeen Centre for Research Excellence in Musculoskeletal Health: Collaborate. Innovate. Translate. | en |
| dc.contributor.institution | University of Aberdeen.Institute of Medical Sciences | en |
| dc.contributor.institution | University of Aberdeen.Medical Sciences - Cell, Developmental and Cancer Biology | en |
| dc.date.accessioned | 2023-04-27T08:45:01Z | |
| dc.date.available | 2023-04-27T08:45:01Z | |
| dc.date.issued | 2023-04-26 | |
| dc.description | Acknowledgements The authors acknowledge support from their associated institutions which included: (i) the Intramural Research Program, National Institute on Aging, NIH, USA, (ii) the Karolinska Institutet, Sweden, (iii) Aevisbio Inc., USA, (iv) Aevis Bio Inc., Republic of Korea, (v) G. d’Annunzio University of Chieti and Pescara, Italy, and (vi) University of Aberdeen, Scotland, UK. Funding The generation of this article was supported by: (i) the Intramural Research Program, National Institute on Aging, NIH: AG000994. (ii) The Technology Development Program of MSS, Republic of Korea (S2782046). (iii) The National Research Foundation (NRF) grant funded by the Republic of Korea Government (2021M3A9G2015889). | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 34 | |
| dc.format.extent | 6954606 | |
| dc.identifier | 239256531 | |
| dc.identifier | 9da4efaa-0bd5-4af3-944b-d5bc1270d8bb | |
| dc.identifier | 37238617 | |
| dc.identifier | 85160373160 | |
| dc.identifier.citation | Kopp, K O, Greer, M E, Glotfelty, E J, Hsueh, S-C, Tweedie, D, Kim, D S, Reale, M, Vargesson, N & Greig, N H 2023, 'A New Generation of IMiDs as Treatments for Neuroinflammatory and Neurodegenerative Disorders', Biomolecules, vol. 13, no. 5, 747. https://doi.org/10.3390/biom13050747 | en |
| dc.identifier.doi | 10.3390/biom13050747 | |
| dc.identifier.issn | 2218-273X | |
| dc.identifier.other | ORCID: /0000-0001-8027-114X/work/145270776 | |
| dc.identifier.uri | https://hdl.handle.net/2164/20579 | |
| dc.language.iso | eng | |
| dc.relation.ispartof | Biomolecules | en |
| dc.subject | SDG 3 - Good Health and Well-being | en |
| dc.subject | Immunomodulatory imide drugs (IMiDs) | en |
| dc.subject | thalidomide | en |
| dc.subject | pomalidomide | en |
| dc.subject | neuroinflammation | en |
| dc.subject | cereblon | en |
| dc.subject | traumatic brain injury; | en |
| dc.subject | Alzheimer’s disease | en |
| dc.subject | Parkinson’s disease | en |
| dc.subject | neurodegeneration | en |
| dc.subject | erythema nodosum leprosum | en |
| dc.subject | R Medicine | en |
| dc.subject.lcc | R | en |
| dc.title | A New Generation of IMiDs as Treatments for Neuroinflammatory and Neurodegenerative Disorders | en |
| dc.type | Journal article | en |
Files
Original bundle
1 - 1 of 1
